Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 12, 2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMTMichel van Gelder, Dimitris Ziagkos, Liesbeth de Wreede, et al.
Leukemia & Lymphoma|June 23, 2022
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working groupDoreen G Te Raa, Lina van der Straten, Michel van Gelder, et al.
British Journal of Haematology|March 10, 2020
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trialJeanette K Doorduijn, Josee M Zijlstra, Pieternella J Lugtenburg, et al.
Bone Marrow Transplantation|March 20, 2024
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTRomain Guièze, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|October 2, 2020
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working partyJohannes Schetelig, Patrice Chevallier, Michel van Gelder, et al.
Leukemia|May 9, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trialGerald G Wulf, Bettina Altmann, Marita Ziepert, et al.
Haematologica|August 18, 2018
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemiaArnon P Kater, Marinus H J van Oers, Yvette van Norden, et al.
Cancer Medicine|April 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modelingSjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, et al.
Blood|January 19, 2017
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelTheo de Witte, David Bowen, Marie Robin, et al.
Pageof 6